 |
|
Prior Authorization for Antidepressants in MedicaidEffects Among Disabled Dual Enrollees
Alyce S. Adams, PhD;
Fang Zhang, PhD;
Robert F. LeCates, MA;
Amy Johnson Graves, MPH;
Dennis Ross-Degnan, ScD;
Daniel Gilden, MS;
Thomas J. McLaughlin, ScD;
Christine Lu, PhD;
Connie M. Trinacty, PhD;
Stephen B. Soumerai, ScD
Arch Intern Med. 2009;169(8):750-756.
Background Prior authorization is a popular, but understudied, strategy for reducing medication costs. We evaluated the impact of a controversial prior authorization policy in Michigan Medicaid on antidepressant use and health outcomes among dual Medicaid and Medicare enrollees with a Social Security Disability Insurance designation of permanent disability.
Methods We linked Medicaid and Medicare (2000-2003) claims for dual enrollees in Michigan and a comparison state, Indiana. Using interrupted time-series and longitudinal data analysis, we estimated the impact of the policy on antidepressant medication use, treatment initiation, disruptions in therapy, and adverse health events among continuously enrolled (Michigan, n = 28 798; Indiana, n = 21 769) and newly treated (Michigan, n = 3671; Indiana, n = 2400) patients.
Results In Michigan, the proportion of patients starting nonpreferred agents declined from 53% prepolicy to 20% postpolicy. The prior authorization policy was associated with a small sustained decrease in therapy initiation overall (9 per 10 000 population; P = .007). We also observed a short-term increase in switching among established users of nonpreferred agents overall (risk ratio, 2.88; 95% confidence interval, 1.87-4.42) and among those with depression (2.04; 1.22-3.42). However, we found no evidence of increased disruptions in treatment or adverse events (ie, hospitalization, emergency department use) among newly treated patients.
Conclusions Prior authorization was associated with increased use of preferred agents with no evidence of disruptions in therapy or adverse health events among new users. However, unintended effects on treatment initiation and switching among patients already taking the drug were also observed, lending support to the state's previous decision to discontinue prior approval for antidepressants in 2003.
Author Affiliations: Kaiser Permanente Division of Research, Oakland, California (Dr Adams); Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts (Drs Adams, Zhang, Ross-Degnan, Lu, Trinacty, and Soumerai, Mr LeCates, and Ms Graves); Jen Associates, Inc, Cambridge, Massachusetts (Mr Gilden); and Department of Pediatrics and Psychiatry, School of Medicine, University of Massachusetts, Worcester (Dr McLaughlin).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLES
In This Issue of Archives of Internal Medicine
Arch Intern Med. 2009;169(8):736.
FULL TEXT
The Change We Need in Health Care
David C. Goff, Jr and Philip Greenland
Arch Intern Med. 2009;169(8):737-739.
EXTRACT
| FULL TEXT
Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill
Matthew D. Solomon, Dana P. Goldman, Geoffrey F. Joyce, and José J. Escarce
Arch Intern Med. 2009;169(8):740-748.
ABSTRACT
| FULL TEXT
Effect of a Pharmacist on Adverse Drug Events and Medication Errors in Outpatients With Cardiovascular Disease
Michael D. Murray, Mary E. Ritchey, Jingwei Wu, and Wanzhu Tu
Arch Intern Med. 2009;169(8):757-763.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The Financial Burden From Prescription Drugs Has Declined Recently For The Nonelderly, Although It Is Still High For Many
Gellad et al.
Health Aff (Millwood) 2012;31:408-416.
ABSTRACT
| FULL TEXT
Prior Authorization of Antidepressants: Effects on Patient Care
JWatch Psychiatry 2009;2009:2-2.
FULL TEXT
The Change We Need in Health Care
Goff and Greenland
Arch Intern Med 2009;169:737-739.
FULL TEXT
|
